Stock of the Day: Hims & Hers plunges 27% after saying it will stop selling its...

Published on 25 Feb 2025 on Business Insider

With Hims & Her's main source of growth set to be extinguished, Citi analysts said its full-year...

Read the rest of the article

Start tracking your investments with Statfolio

Hims & Hers Health (NYSE:HIMS) just took a brutal hit, with shares nosediving over 27% at 11.42am...

GuruFocus.com · via Yahoo Finance 25 Feb 2025

With Hims & Her's main source of growth set to be extinguished, Citi analysts said its full-year...

Business Insider 25 Feb 2025

Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released...

CNBC 25 Feb 2025

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheape...

Insider Monkey · via Yahoo Finance 25 Feb 2025

After the FDA declared the Ozempic shortage over, Hims & Hers can no longer sell its off-brand...

Quartz 25 Feb 2025

We recently published a list of Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against...

Insider Monkey · via Yahoo Finance 25 Feb 2025

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims...

Business Insider 25 Feb 2025

Hims & Hers' revenue channels witness strong growth on the back of solid product demand in the...

Zacks 25 Feb 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4...

StockStory · via Yahoo Finance 24 Feb 2025

Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America...

Motley Fool · via Yahoo Finance 20 Feb 2025